Actively Recruiting
Assessing Central Aspects of Pain
Led by University of Nottingham · Updated on 2026-04-08
250
Participants Needed
1
Research Sites
101 weeks
Total Duration
On this page
Sponsors
U
University of Nottingham
Lead Sponsor
K
King's College London
Collaborating Sponsor
AI-Summary
What this Trial Is About
BACKGROUND: Chronic pain continues for more than 12 weeks despite medication or treatment. Chronic pain is the main symptom of muscle and joint problems, rarely explained by damage to the muscle and joints alone. Activity in the central nervous system (CNS; nerves, spinal cord, and brain) pathways governs our ability to describe pain intensity and our emotional response to pain. Musculoskeletal conditions (e.g., inflammatory arthritis, osteoarthritis, low back pain, fibromyalgia) share altered CNS pathways, acknowledged by recent classifications of 'primary' and 'nociplastic' pain. Clinically useful tools to diagnose and measure activity and reveal abnormalities in these CNS pathways are needed to improve clinical decisions and accelerate new treatment development. Laboratory pain sensitivity testing and brain imaging confirm the CNS as a primary contributor to pain. These assessments are less acceptable or unfeasible for clinical practice. Simpler clinical pain sensitivity assessments are being developed. The investigators simple Central Aspects of Pain (CAP) questionnaire detects some people with pain sensitivity and knee, rheumatoid arthritis or low back pain. Combining the CAP questionnaire reflecting emotional processing and simpler pain sensitivity assessment, combining two different dimensions should be better than either approach alone. PURPOSE: To optimise diagnosis and measurement of CNS as the primary contribution to chronic musculoskeletal pain by using the CAP questionnaire and simpler pain sensitivity assessments to ensure timely, effective diagnosis and treatment. OBJECTIVES: 1. Assess the ease, ability and performance of the combined CAP questionnaire and simpler pain sensitivity assessments to identify CNS as the primary contributor to chronic pain across musculoskeletal conditions. 2\. Use the CAP questionnaire alone or with substitute measures of activity in CNS pathways, demographic, and clinical variables to indicate pain levels at six and twelve weeks. 3\. Understand the relationship between CAP and simpler pain sensitivity assessment with laboratory pain sensitivity assessments as a tool to inform the current CNS activity contributing to pain. 4\. Evaluate associations between the CAP questionnaire and simpler pain sensitivity assessments with patient outcomes.
CONDITIONS
Official Title
Assessing Central Aspects of Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or over.
- Self-reported diagnosis of fibromyalgia, inflammatory musculoskeletal condition (e.g., rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis), low back pain, or osteoarthritis.
- Musculoskeletal diagnosis and pain onset more than 3 months before baseline.
- Self-reported pain level of 3 or higher on a 0 to 10 scale on most days in the 3 months before baseline.
- Ability to give informed consent.
You will not qualify if you...
- Terminal or uncontrolled medical or mental health condition preventing completion of assessments or posing significant risk.
- Insufficient understanding of spoken or written English to follow the study protocol.
- Inability to adhere to the study protocol.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Nottingham, Academic Rheumatology, IRIS, School of Medicine
Nottingham, Nottingham, United Kingdom, NG5 1PB
Actively Recruiting
Research Team
S
Stephanie L Smith, PhD
CONTACT
D
David A Walsh, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here